Content-Length: 344140 | pFad | https://doi.org/10.1007/s00213-005-0009-4

a=86400 Hallucinogen-like actions of 2,5-dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7) in mice and rats | Psychopharmacology Skip to main content
Springer Nature Link
Log in

Hallucinogen-like actions of 2,5-dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7) in mice and rats

  • Original Investigation
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Rationale

Few studies have examined the effects of 2,5-dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7) in vivo.

Objectives

2C-T-7 was tested in a drug-elicited head twitch assay in mice and in several drug discrimination assays in rats; 2C-T-7 was compared to the phenylisopropylamine hallucinogen R(−)-1-(2,5-dimethoxy-4-methylphenyl)-2aminopropane (DOM) in both assays, with or without pretreatment with the selective 5-HT2A antagonist (+)-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenylethyl)]-4-piperidine-methanol (M100907). Finally, the affinity of 2C-T-7 for three distinct 5-HT receptors was determined in rat brain.

Methods

Drug-elicited head twitches were quantified for 10 min following administration of various doses of either 2C-T-7 or R(−)-DOM, with and without pretreatments of 0.01 mg/kg M100907. In rats trained to discriminate lysergic acid diethylamide (LSD), 2C-T-7 and R(−)-DOM were tested for generalization. In further studies, rats were trained to discriminate 2C-T-7 from saline, then challenged with 0.05 mg/kg M100907. In competition binding studies, the affinity of 2C-T-7 was assessed at 5-HT2A receptors, 5-HT1A receptors, and 5-HT2C receptors.

Results

2C-T-7 and R(−)-DOM induced similar head twitch responses in the mouse that were antagonized by M100907. In the rat, 2C-T-7 produced an intermediate degree of generalization (75%) to the LSD cue and served as a discriminative stimulus; these interoceptive effects were attenuated by M100907. Finally, 2C-T-7 had nanomolar affinity for 5-HT2A and 5-HT2C receptors and lower affinity for 5-HT1A receptors.

Conclusions

2C-T-7 is effective in two rodent models of 5-HT2 agonist activity and has affinity at receptors relevant to hallucinogen effects. The effectiveness with which M100907 antagonizes the behavioral actions of 2C-T-7 strongly suggests that the 5-HT2A receptor is an important site of action for this compound.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  • Aceto MD, Mckean DB, Pearl J (1969) Effects of opiates and opiate antagonists on the straub tail reaction in mice. Br J Pharmacol 36:239–255

    Google Scholar 

  • Aghajanian GK, Marek GJ (1999) Serotonin and hallucinogens. Neuropsychopharmacology 21(2S):16S–23S

    PubMed  CAS  Google Scholar 

  • Boulton CS, Handley SL (1973) Factors modifying the head-twitch response to 5-hydroxytryptophan. Psychopharmacologia 31(3):205–214

    Article  PubMed  CAS  Google Scholar 

  • Brauer LH, Goudie AJ, de Wit H (1997) Dopamine ligands and the stimulus effects of amphetamine: animal models versus human laboratory data. Psychopharmacology 130:2–13

    Article  PubMed  CAS  Google Scholar 

  • Brown JB (2002) Schedules of controlled substances: temporary placement of 2,5-dimethoxy-4-(n)-propylthiophenethylamine into Schedule I. Fed Regist 67(183):59163–59165

    Google Scholar 

  • Colpaert FC, Janssen PAJ (1983) The head twitch response to intraperitoneal injection of 5-hydroxytryptophan in the rat: antagonist effects of purported 5-hydroxytryptamine antagonists and of pirenperone, an LSD antagonist. Neuropharmacology 22(8):993–1000

    Article  PubMed  CAS  Google Scholar 

  • Corne SJ, Pickering RW (1967) A possible correlation between drug-induced hallucinations in man and a behavioral response in mice. Psychopharmacologia 11:65–78

    Article  PubMed  CAS  Google Scholar 

  • Corne SJ, Pickering RW, Warner BT (1963) A method for assessing the effects of drugs on the central actions of 5-hydroxytryptamine. Br J Pharmacol 20:106–120

    CAS  Google Scholar 

  • Darmani NA (1998) Cocaine and selective monoamine uptake blockers (sertraline, nisoxetine, and GBR 12935) prevent the d-fenfluramine-induced head-twitch response in mice. Pharmacol Biochem Behav 60(1):83–90

    Article  PubMed  CAS  Google Scholar 

  • Darmani NA, Martin BR, Glennon RA (1990a) Withdrawal from chronic treatment with (±)-DOI causes supersensitivity to 5-HT2 receptor-induced head-twitch behavior in mice. Eur J Pharmacol 186:115–118

    Article  PubMed  CAS  Google Scholar 

  • Darmani NA, Martin BR, Pandy U, Glennon RA (1990b) Do functional relationships exist between 5-HT1A and 5-HT2 receptors? Pharmacol Biochem Behav 36(4):901–906

    Article  PubMed  CAS  Google Scholar 

  • Darmani NA, Martin BR, Glennon RA (1992) Behavioral evidence for differential adaptation of the serotonergic system after acute and chronic treatment with (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) or ketanserin. J Pharmacol Exp Ther 262(2):692–698

    PubMed  CAS  Google Scholar 

  • Dave KD, Harvey JA, Aloyo VJ (2002) A novel behavioral model that discriminates between 5-HT2A and 5-HT2C receptor activation. Pharmacol Biochem Behav 72:371–378

    Article  PubMed  CAS  Google Scholar 

  • de Boer D, Bosman I (2004) A new trend in drugs-of-abuse; the 2C-series of phenethylamine designer drugs. Pharm World Sci 26(2):110–113

    Article  PubMed  Google Scholar 

  • Dursun SM, Handley SL (1996) Similarities in the pharmacology of spontaneous and DOI-induced head-shakes suggest 5-HT2A receptors are active under physiological conditions. Psychopharmacology 128:198–205

    Article  PubMed  CAS  Google Scholar 

  • Fantegrossi WE, Kilbourn ME, Woods JH (2004a) Actions of the 5-HT2A antagonist M100907 in serotonin-depleted mice. 2004 Experimental Biology meeting abstracts [accessed at http://select.biosis.org/faseb]. FASEB J, 18, Abstract #637.2

  • Fantegrossi WE, Kiessel CL, Leach PT, Van Martin C, Karabenick RL, Chen X, Ohizumi Y, Ullrich T, Rice KC, Woods JH (2004b) Nantenine: an antagonist of the behavioral and physiological effects of MDMA in mice. Psychopharmacology 173(3–4):270–277

    Article  PubMed  CAS  Google Scholar 

  • Fiorella D, Palumbo PA, Rabin RA, Winter JC (1995a) The time-dependent stimulus effects of R(−)-2,5-dimethoxy-4-methamphetamine (DOM): implications for drug-induced stimulus control as a method for the study of hallucinogenic agents. Psychopharmacology 119:239–245

    Article  PubMed  CAS  Google Scholar 

  • Fiorella D, Rabin RA, Winter JC (1995b) The role of the 5-HT2A and 5-HT2C receptors in the stimulus effects of hallucinogenic drugs I: antagonist correlation analysis. Psychopharmacology 121:347–356

    Article  PubMed  CAS  Google Scholar 

  • Fozard JR, Palfreyman MG (1979) Metoclopramide antagonism of 5-HT-induced “wet-dog” shake behavior in the rat. N-S Arch Pharmacol 307:135–142

    Article  CAS  Google Scholar 

  • Glennon RA, Young R, Jacyno JM, Slusher M, Rosecrans JA (1983a) DOM-stimulus generalization to LSD and other hallucinogenic indolealkylamines. Eur J Pharmacol 86:453–459

    Article  PubMed  CAS  Google Scholar 

  • Glennon RA, Rosecrans JA, Young R (1983b) Drug-induced discrimination: a description of the paradigm and a review of its specific application to the study of hallucinogenic agents. Med Res Rev 3:289–340

    Article  PubMed  CAS  Google Scholar 

  • Goodwin GM, Green AR (1985) A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors. Br J Pharmacol 84(3):743–755

    PubMed  CAS  Google Scholar 

  • Green AR, O'Shaughnessy K, Hammond M, Schachter M, Grahame-Smith DG (1983) Inhibition of 5-hydroxytryptamine-mediated behaviours by the putative 5-HT2 receptor antagonist pirenperone. Neuropharmacology 22:573–578

    Article  PubMed  CAS  Google Scholar 

  • Handley SL, Singh L (1986) Neurotransmitters and shaking behavior: more than a “gut bath” for the brain. Trends Pharmacol Sci 7:324–328

    Article  CAS  Google Scholar 

  • Khorana N, Pullagurla MR, Dukat M, Young R, Glennon R (2004) Stimulus effects of three sulfur-containing psychoactive agents. Pharmacol Biochem Behav 78:821–826

    Article  PubMed  CAS  Google Scholar 

  • Leonhart MM (2004) Schedules of controlled substances: placement of 2,5-dimethoxy-4-(n)-propylthiophenethylamine and N-benzylpiperazine into Schedule 1 of the controlled substances act. Fed Regist 69(53):12795–12797

    Google Scholar 

  • Lucki I, Nobler MS, Frazer A (1984) Differential actions of serotonin antagonists on two behavioral models of serotonin receptor activation in the rat. J Pharmacol Exp Ther 228:133–139

    PubMed  CAS  Google Scholar 

  • Nichols DE (2004) Hallucinogens. Pharmacol Ther 101:131–181

    Article  PubMed  CAS  Google Scholar 

  • Ortmann R, Biscoff S, Radeke E, Bueche O, Delini-Stula A (1982) Correlation between different measures of antiserotonin activity of drugs. Naunyn-Schmiedeberg's Arch Pharmacol 321:265–270

    Article  CAS  Google Scholar 

  • Peroutka SJ, Lebovitz RM, Snyder SH (1981) Two distinct central serotonin receptors with different physiological functions. Science (Wash DC) 212:827–829

    Article  CAS  Google Scholar 

  • Sadzot B, Baraban JM, Glennon RA, Lyon RA (1989) Hallucinogenic drug interactions at human brain 5-HT2 receptors: implications for treating LSD-induced hallucinogenesis. Psychopharmacology 98(4):495–499

    Article  PubMed  CAS  Google Scholar 

  • Sanger DJ, Benavides J, Perrault G, Morel E, Cohen C, Joly D, Zivkovic B (1994) Recent developments in the behavioral pharmacology of benzodiazepine (ω) receptors: evidence for functional significance of receptor subtypes. Neurosci Biobehav Rev 18:355–372

    Article  PubMed  CAS  Google Scholar 

  • Schreiber R, Brocco M, Audinot V, Gobert A, Veiga S, Millan MJ (1995) (1-(2,5-Dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT)2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists. J Pharmacol Exp Ther 273:101–112

    PubMed  CAS  Google Scholar 

  • Schuster C, Johanson C (1988) Relationship between the discriminative stimulus properties and subjective effects of drugs. In: Colpaert F, Balster R (eds) Transduction mechanisms of drug stimuli. Springer, Berlin Heidelberg New York, pp 161–175

    Google Scholar 

  • Shulgin A, Shulgin A (1991) PIHKAL: a chemical love story. Transform Press, Berkley, pp 567–571

    Google Scholar 

  • Strassman RJ, Qualls CR, Berg LM (1996) Differential tolerance to biological and subjective effects of 4 closely spaced doses of N,N-dimethyltryptamine in humans. Biol Psychiatry 39:784–795

    Article  PubMed  CAS  Google Scholar 

  • Vollenweider FX (1998) Advances and pathophysiological models of hallucinogenic drug actions in humans: a preamble to schizophrenia research. Pharmacopsychiatry 31:92–103

    Article  PubMed  CAS  Google Scholar 

  • Winter JC (1978) Stimulus properties of phenethylamine hallucinogens and lysergic acid diethylamide: the role of 5-hydroxytryptamine. J Pharmacol Exp Ther 204:416–423

    PubMed  CAS  Google Scholar 

  • Winter JC, Rabin RA (1988) Interactions between serotonergic agonists and antagonists in rats trained with LSD as a discriminative stimulus. Pharmacol Biochem Behav 30:617–624

    Article  PubMed  CAS  Google Scholar 

  • Winter JC, Eckler JR, Rabin RA (2004) Serotonergic/glutamatergic interactions: the effects of mGlu2/3 receptor ligands in rats trained with LSD and PCP as discriminative stimuli. Psychopharmacology 172:233–240

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Neuroscience, Yerkes National Primate Research Center, Emory University, 954 Gatewood Drive, Atlanta, GA, 30322, USA

    William E. Fantegrossi

  2. Department of Pharmacology, University of Michigan Medical School, 1301 MSRB III, Ann Arbor, MI, 48109-0632, USA

    William E. Fantegrossi, Andrew W. Harrington & James H. Woods

  3. Department of Pharmacology, School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, NY, 14214, USA

    Justin R. Eckler, Sadia Arshad, Richard A. Rabin & Jerrold C. Winter

  4. Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, 20 N. Pine Street, Baltimore, MD, 21201, USA

    Andrew Coop

  5. Laboratory of Medicinal Chemistry, NIDDK, National Institutes of Health, Building 8, Room B1-21, Bethesda, MD, 20892, USA

    Kenner C. Rice

Authors
  1. William E. Fantegrossi
    View author publications

    You can also search for this author inPubMed Google Scholar

  2. Andrew W. Harrington
    View author publications

    You can also search for this author inPubMed Google Scholar

  3. Justin R. Eckler
    View author publications

    You can also search for this author inPubMed Google Scholar

  4. Sadia Arshad
    View author publications

    You can also search for this author inPubMed Google Scholar

  5. Richard A. Rabin
    View author publications

    You can also search for this author inPubMed Google Scholar

  6. Jerrold C. Winter
    View author publications

    You can also search for this author inPubMed Google Scholar

  7. Andrew Coop
    View author publications

    You can also search for this author inPubMed Google Scholar

  8. Kenner C. Rice
    View author publications

    You can also search for this author inPubMed Google Scholar

  9. James H. Woods
    View author publications

    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence to William E. Fantegrossi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fantegrossi, W.E., Harrington, A.W., Eckler, J.R. et al. Hallucinogen-like actions of 2,5-dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7) in mice and rats. Psychopharmacology 181, 496–503 (2005). https://doi.org/10.1007/s00213-005-0009-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00213-005-0009-4

Keywords









 ApplySandwichStrip

pFad - (p)hone/(F)rame/(a)nonymizer/(d)eclutterfier!      Saves Data!


--- a PPN by Garber Painting Akron. With Image Size Reduction included!

Fetched URL: https://doi.org/10.1007/s00213-005-0009-4

Alternative Proxies:

Alternative Proxy

pFad Proxy

pFad v3 Proxy

pFad v4 Proxy